{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:13:13Z","timestamp":1790172793757,"version":"4.1.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0120545","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T18:49:18Z","timestamp":1427136558000},"page":"e0120545","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status"],"prefix":"10.1371","volume":"10","author":[{"given":"Kazuaki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw","family":"Htet Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.critrevonc.2008.09.008","article-title":"Cholangiocarcinoma","volume":"69","author":"S Mosconi","year":"2009","journal-title":"Critical reviews in oncology\/hematology"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.dld.2009.12.008","article-title":"Cholangiocarcinoma: update and future perspectives","volume":"42","author":"M Gatto","year":"2010","journal-title":"Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2004.07.035","article-title":"An increasing incidence of cholangiocarcinoma: why?","volume":"127","author":"L Blendis","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"B Blechacz","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"PA Jones","year":"2007","journal-title":"Cell"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng1990","article-title":"Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome","volume":"39","author":"M Weber","year":"2007","journal-title":"Nature genetics"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/72785","article-title":"Aberrant CpG-island methylation has non-random and tumour-type-specific patterns","volume":"24","author":"JF Costello","year":"2000","journal-title":"Nature genetics"},{"issue":"29","key":"ref8","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.3748\/wjg.v17.i29.3407","article-title":"Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma. World journal of gastroenterology","volume":"17","author":"Y Shu","year":"2011","journal-title":"WJG"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"AP Feinberg","year":"2004","journal-title":"Nature reviews Cancer"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"AP Feinberg","year":"2006","journal-title":"Nature reviews Genetics"},{"issue":"54","key":"ref11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1126\/scitranslmed.3001338","article-title":"An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer","volume":"2","author":"JB Andersen","year":"2010","journal-title":"Science translational medicine"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4161\/epi.6.11.17993","article-title":"DNA methylation imprinting marks and DNA methyltransferase expression in human spermatogenic cell stages","volume":"6","author":"CJ Marques","year":"2011","journal-title":"Epigenetics: official journal of the DNA Methylation Society"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1101\/gr.119487.110","article-title":"DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer","volume":"21","author":"Y Kobayashi","year":"2011","journal-title":"Genome research"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/1541-7786.62.2.1","article-title":"Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation","volume":"2","author":"DJ Weisenberger","year":"2004","journal-title":"Molecular cancer research: MCR"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1309\/AJCPHGQ69FXDFWII","article-title":"Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis","volume":"134","author":"Y Qu","year":"2010","journal-title":"American journal of clinical pathology"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1349-7006.2010.01569.x","article-title":"DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas","volume":"101","author":"K Amara","year":"2010","journal-title":"Cancer science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/1476-4598-9-305","article-title":"Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation","volume":"9","author":"GL Gravina","year":"2010","journal-title":"Molecular cancer"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1158\/1078-0432.CCR-05-0050","article-title":"Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine","volume":"11","author":"H Dote","year":"2005","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/1078-0432.CCR-08-2783","article-title":"Targeting DNA methylation","volume":"15","author":"JP Issa","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/00365520600874198","article-title":"Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models","volume":"42","author":"D Neureiter","year":"2007","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"Suppl 1","key":"ref21","first-page":"51","article-title":"5-Aza-2'-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends","volume":"7","author":"A Pinto","year":"1993","journal-title":"Leukemia"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006388031954","article-title":"A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer","volume":"18","author":"G Schwartsmann","year":"2000","journal-title":"Investigational new drugs"},{"issue":"21","key":"ref23","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1158\/0008-5472.CAN-06-2130","article-title":"Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression","volume":"66","author":"H Wehbe","year":"2006","journal-title":"Cancer research"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/theoncologist.2012-0465","article-title":"Concise drug review: azacitidine and decitabine","volume":"18","author":"EJ Derissen","year":"2013","journal-title":"The oncologist"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4419-9967-2_13","article-title":"Epigenetic therapies in MDS and AML","volume":"754","author":"EA Griffiths","year":"2013","journal-title":"Advances in experimental medicine and biology"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccr.2004.06.023","article-title":"Preferential response of cancer cells to zebularine","volume":"6","author":"JC Cheng","year":"2004","journal-title":"Cancer cell"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/jmbi.1998.2491","article-title":"Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone","volume":"286","author":"PJ Hurd","year":"1999","journal-title":"Journal of molecular biology"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jnci\/95.5.399","article-title":"Inhibition of DNA methylation and reactivation of silenced genes by zebularine","volume":"95","author":"JC Cheng","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"issue":"Pt 6","key":"ref29","first-page":"910","article-title":"Zebularine: a new drug for epigenetic therapy","volume":"32","author":"CB Yoo","year":"2004","journal-title":"Biochemical Society transactions"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/MCB.24.3.1270-1278.2004","article-title":"Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells","volume":"24","author":"JC Cheng","year":"2004","journal-title":"Molecular and cellular biology"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"e54036","DOI":"10.1371\/journal.pone.0054036","article-title":"DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis","volume":"8","author":"K Nakamura","year":"2013","journal-title":"PloS one"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.177.61","article-title":"Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1","volume":"177","author":"S Saijyo","year":"1995","journal-title":"The Tohoku journal of experimental medicine"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02623562","article-title":"A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19\/9 in serum-free medium","volume":"25","author":"M Miyagiwa","year":"1989","journal-title":"In vitro cellular & developmental biology: journal of the Tissue Culture Association"},{"issue":"18","key":"ref34","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3748\/wjg.v11.i18.2748","article-title":"Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines","volume":"11","author":"N Tepsiri","year":"2005","journal-title":"World journal of gastroenterology: WJG"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3748\/wjg.v11.i2.249","article-title":"Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma","volume":"11","author":"A Juntavee","year":"2005","journal-title":"World journal of gastroenterology: WJG"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ygeno.2011.07.007","article-title":"High density DNA methylation array with single CpG site resolution","volume":"98","author":"M Bibikova","year":"2011","journal-title":"Genomics"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-009-0420-3","article-title":"Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells","volume":"120","author":"M Billam","year":"2010","journal-title":"Breast cancer research and treatment"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1007\/s11033-012-1837-z","article-title":"Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis","volume":"39","author":"BR You","year":"2012","journal-title":"Molecular biology reports"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.26721","article-title":"Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway","volume":"59","author":"B Goeppert","year":"2014","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/srep03219","article-title":"Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress","volume":"3","author":"PM Yang","year":"2013","journal-title":"Scientific reports"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ijc.26107","article-title":"The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells","volume":"130","author":"MJ Ruiz-Magana","year":"2012","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1073\/pnas.88.8.3470","article-title":"High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer","volume":"88","author":"WS el-Deiry","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/mc.10033","article-title":"DNA methyltransferase and demethylase in human prostate cancer","volume":"33","author":"SK Patra","year":"2002","journal-title":"Molecular carcinogenesis"},{"issue":"12","key":"ref44","first-page":"4415","article-title":"Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas","volume":"9","author":"I Girault","year":"2003","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"1","key":"ref45","first-page":"65","article-title":"DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation","volume":"20","author":"BK Oh","year":"2007","journal-title":"International journal of molecular medicine"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.leu.2400932","article-title":"Increased DNA methyltransferase expression in leukaemia","volume":"12","author":"JR Melki","year":"1998","journal-title":"Leukemia"},{"issue":"17","key":"ref47","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/092986709788612738","article-title":"Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases","volume":"16","author":"TE Fandy","year":"2009","journal-title":"Current medicinal chemistry"},{"issue":"Spec No 1","key":"ref48","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1093\/hmg\/ddm021","article-title":"Cancer genetics of epigenetic genes","volume":"16","author":"A Miremadi","year":"2007","journal-title":"Human molecular genetics"},{"issue":"3\u20134","key":"ref49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000015331","article-title":"Assignment of cytosine-5 DNA methyltransferases Dnmt3a and Dnmt3b to mouse chromosome bands 12A2-A3 and 2H1 by in situ hybridization","volume":"86","author":"M Okano","year":"1999","journal-title":"Cytogenetics and cell genetics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fonc.2014.00080","article-title":"DNA methyltransferases: a novel target for prevention and therapy","volume":"4","author":"D Subramaniam","year":"2014","journal-title":"Frontiers in oncology"},{"issue":"24","key":"ref51","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2174\/092986705774454706","article-title":"Non-hydroxamate histone deacetylase inhibitors","volume":"12","author":"T Suzuki","year":"2005","journal-title":"Current medicinal chemistry"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.153.4.1778","article-title":"Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest","volume":"153","author":"M Leist","year":"1994","journal-title":"J Immunol"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/jhep.2002.34615","article-title":"Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells","volume":"36","author":"C Liedtke","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1038\/35008695","article-title":"Rb function in cell-cycle regulation and apoptosis","volume":"2","author":"JW Harbour","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00018-002-8410-1","article-title":"Regulation of cyclin-Cdk activity in mammalian cells. Cellular and molecular life sciences","volume":"59","author":"AJ Obaya","year":"2002","journal-title":"CMLS"},{"issue":"9","key":"ref56","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia","volume":"101","author":"D Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/path.1692","article-title":"Wnt signalling and the mechanistic basis of tumour development","volume":"205","author":"M Ilyas","year":"2005","journal-title":"The Journal of pathology"},{"issue":"4","key":"ref58","first-page":"973","article-title":"Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas","volume":"27","author":"N Tokumoto","year":"2005","journal-title":"International journal of oncology"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/modpathol.3880409","article-title":"Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma","volume":"14","author":"K Sugimachi","year":"2001","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3892\/or.2013.2560","article-title":"Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells","volume":"30","author":"KS Zhang","year":"2013","journal-title":"Oncology reports"},{"issue":"Pt 13","key":"ref61","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1242\/jcs.00623","article-title":"Secreted antagonists of the Wnt signalling pathway","volume":"116","author":"Y Kawano","year":"2003","journal-title":"J Cell Sci"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1158\/1078-0432.CCR-04-2406","article-title":"Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine","volume":"11","author":"JL Holleran","year":"2005","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0120545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T23:31:03Z","timestamp":1691537463000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0120545"}},"subtitle":[],"editor":[{"given":"Diego","family":"Calvisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0120545","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}